
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
[ Fri, Jan 17th 2020 ]: WOPRAI
Matthew Harrison Maintained (BIIB) at Sell with Increased Target to $270 on, Jan 17th, 2020


🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Sell with Increased Target from $262 to $270 on, Jan 17th, 2020.
Matthew has made no other calls on BIIB in the last 4 months.
There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 4 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Evan Seigerman of "Credit Suisse" Upgraded from Sell to Hold and Increased Target to $300 on, Friday, December 13th, 2019
- Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $260 on, Wednesday, October 23rd, 2019
- Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $297 on, Wednesday, October 23rd, 2019
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $305 on, Wednesday, October 23rd, 2019
These are the ratings of the 7 analyists that currently disagree with Matthew
- Brian Skorney of "Baird" Downgraded from Hold to Sell and Held Target at $250 on, Monday, December 2nd, 2019
- Robyn Karnauskas of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $337 on, Tuesday, November 12th, 2019
- Aaron Gal of "Bernstein" Upgraded from Hold to Buy on, Wednesday, October 30th, 2019
- Adnan Butt of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, October 23rd, 2019
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $335 on, Wednesday, October 23rd, 2019
- Marc Goodman of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $350 on, Wednesday, October 23rd, 2019
- Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $325 on, Wednesday, October 23rd, 2019
Similar Stocks and Investing Publications
[ Tue, Dec 24th 2019 ]: WOPRAI
[ Mon, Dec 16th 2019 ]: WOPRAI
[ Fri, Dec 13th 2019 ]: WOPRAI
[ Mon, Dec 02nd 2019 ]: WOPRAI
[ Tue, Nov 12th 2019 ]: WOPRAI
[ Tue, Nov 12th 2019 ]: WOPRAI
[ Wed, Oct 30th 2019 ]: WOPRAI
[ Mon, Feb 05th 2018 ]: WOPRAI
[ Wed, Jan 31st 2018 ]: WOPRAI
[ Fri, Jan 26th 2018 ]: WOPRAI
[ Fri, Jan 26th 2018 ]: WOPRAI
[ Wed, Jan 24th 2018 ]: WOPRAI